So can you tell me more about his background, the whole setup and kind of what he's working on right now?

Yeah, 100%.

So he's a strong full-stack engineer, used to work at Google.

And when he first joined Eleven Labs, he ran our SEO and website team.

And so he's still doing that.

There's a great friendly competition between our SEO channels and our paid channels of who can drive more revenue, sells leads for the company.

And surprisingly, SEO is definitely not dead.

What have you learned now about using AI that you wish you could go back and kind of tell yourself a year ago or someone on your team?

Yeah

... spoke to you at the time about some of this stuff, and so we were just going really deep on this kind of men's binge eating, men's weight loss space.

And we set up a digital CBT clinic around how do you help people who are struggling with these eating issues? But the tricky thing with digital CBT is it's great for lots of people, but it really only lasts about six weeks from a business point of view.

You can help them get to a great place, but we wanted to have, like, a much bigger impact and build a much bigger business.

And so that's when we were exploring, like, okay, what are the health tech business models which can really grow and really make a lot of sense? And it seemed to be kind of you needed a hardware piece or a medication piece, and we're like: None of these quite make sense, until we read the GLP-1 paper the day it came out.

So this is semaglutide, and we're like: "Wow, this is like the biggest thing in medicine since penicillin." So we, like, race, we set up a clinic.

We're like: "How do we help people get access to this fantastic medication, which reduces people's body weight by 15%?" And we managed to get to about 300K of revenue, which was great, and then it kind of flatlined, and this was the first company I'd really started.

How has a horizontal product offering worked so well when it is completely counter the narrative that we're always told?

Yeah.

... spoke to you at the time about some of this stuff.

And so we were just going really deep on this kind of men's binge eating, men's weight loss space.

And we set up a digital CBT clinic around, how do you help people who are struggling with these eating issues? But the tricky thing with digital CBT is it's great for lots of people, but really only lasts about six weeks from a business point of view.

You can help them get to a great place, but we wanted to have, like, a much bigger impact and build a much bigger business.

And so that's when we were exploring like, "Okay, what are the health tech business models which can really grow and really make a lot of sense?" And it seemed to be kind of you needed a hardware piece or a medication piece, and we're like, "None of these quite make sense," until we read the GLP-1 paper the day it came out.

So this is semaglutide, and we're like, "Wow, this is, like, the biggest thing in medicine since penicillin." So we, like, raced.

How has a horizontal product offering worked so well when it is completely counter the narrative that we're always told?